Skip to main content
. 2016 Jul 20;113(31):8771–8776. doi: 10.1073/pnas.1502166113

Fig. S7.

Fig. S7.

CRBN does not affect Kv1.3 protein half-life. Jurkat-MigR1 and Jurkat-HA-CRBN cells were treated with cycloheximide (CHX; 20 μg/mL), and Kv1.3 protein levels in those cells were analyzed by using immunoblot analysis with anti-Kv1.3 antibody. GAPDH served as an internal control. Data are representative of three independent experiments. Results are expressed as mean ± SD.